The sequencing of the human genome coupled with continued advances in proteomics and genomics have led to an unprecedented understanding of the relationship between genetic content and disease. As a consequence, the development of transcription-based therapeutics that would selectively reprogram aberrant gene expression in diseased cells is an increasingly attractive goal. There remain, however, fundamental questions surrounding the regulatory mechanism of transcription as well as the requirements for specificity and activity of such non-natural transcription factors. Many of these questions have proven intractable by genetic or biochemical means alone. Described herein is an approach for the generation of unique chemical tools that will be used for addressing basic questions of transcriptional regulation. These tools will further serve as molecular targets for the long-term development of transcription-based therapeutics. Saccharomyces cerevisiae or budding yeast will serve as our model system due to the mechanistic homology with mammalian systems, the availability of genomic information, and because yeast-specific transcriptional activators and/or repressors will serve as excellent candidates for anti-fungal agents. In order to accomplish these goals, transcriptional regulators will be selected from libraries of peptides screened for binding to the Mediator complex component Gall 1. A battery of biochemical techniques will be used to characterize the binding affinity and specificity of all ligands thus selected. In vitro transcription experiments will be employed to functionally characterize the ligands as activators or inhibitors of transcription that will be used to probe mechanistic questions surrounding transcriptional regulation in experiments designed to map functionally important protein-protein interactions and to probe the origin of synergy in transcriptional activation. As Saccharomyces cerevisiae is an excellent model system for metazoans, the data thus obtained will significantly contribute to the evolving model of eukaryotic transcriptional activation. Furthermore, the chemical regulators developed throughout the project will serve as the basis for achievement of the long-term goal of the design and investigation of transcription-based therapeutics. The protein under investigation, Galil, is a yeast-specific component of the transcriptional apparatus; thus artificial regulators that exert their function via specific interactions with Gall 1 will function only in yeast, providing a mechanism for the development of anti-fungal agents.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
3R01GM065330-02S1
Application #
6798076
Study Section
Bio-Organic and Natural Products Chemistry Study Section (BNP)
Program Officer
Tompkins, Laurie
Project Start
2002-04-01
Project End
2007-03-31
Budget Start
2003-04-01
Budget End
2004-03-31
Support Year
2
Fiscal Year
2003
Total Cost
$40,000
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Cesa, Laura C; Shao, Hao; Srinivasan, Sharan R et al. (2018) X-linked inhibitor of apoptosis protein (XIAP) is a client of heat shock protein 70 (Hsp70) and a biomarker of its inhibition. J Biol Chem 293:2370-2380
Pricer, Rachel; Gestwicki, Jason E; Mapp, Anna K (2017) From Fuzzy to Function: The New Frontier of Protein-Protein Interactions. Acc Chem Res 50:584-589
Dugan, Amanda; Majmudar, Chinmay Y; Pricer, Rachel et al. (2016) Discovery of Enzymatic Targets of Transcriptional Activators via in Vivo Covalent Chemical Capture. J Am Chem Soc 138:12629-35
Mapp, Anna K; Pricer, Rachel; Sturlis, Steven (2015) Targeting transcription is no longer a quixotic quest. Nat Chem Biol 11:891-4
Lancia, Jody K; Nwokoye, Adaora; Dugan, Amanda et al. (2014) Sequence context and crosslinking mechanism affect the efficiency of in vivo capture of a protein-protein interaction. Biopolymers 101:391-7
Wang, Ningkun; Lodge, Jean M; Fierke, Carol A et al. (2014) Dissecting allosteric effects of activator-coactivator complexes using a covalent small molecule ligand. Proc Natl Acad Sci U S A 111:12061-6
Wang, Ningkun; Majmudar, Chinmay Y; Pomerantz, William C et al. (2013) Ordering a dynamic protein via a small-molecule stabilizer. J Am Chem Soc 135:3363-6
Pomerantz, William C; Wang, Ningkun; Lipinski, Ashley K et al. (2012) Profiling the dynamic interfaces of fluorinated transcription complexes for ligand discovery and characterization. ACS Chem Biol 7:1345-50
Thompson, Andrea D; Dugan, Amanda; Gestwicki, Jason E et al. (2012) Fine-tuning multiprotein complexes using small molecules. ACS Chem Biol 7:1311-20
Krishnamurthy, Malathy; Dugan, Amanda; Nwokoye, Adaora et al. (2011) Caught in the act: covalent cross-linking captures activator-coactivator interactions in vivo. ACS Chem Biol 6:1321-6

Showing the most recent 10 out of 29 publications